{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:52:29Z","timestamp":1794855149726,"version":"4.9.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["MOET32023-0005"],"award-info":[{"award-number":["MOET32023-0005"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["MOE-000387-00"],"award-info":[{"award-number":["MOE-000387-00"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["20210302123299"],"award-info":[{"award-number":["20210302123299"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001388-00"],"award-info":[{"award-number":["MOH-001388-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CG21APR1005"],"award-info":[{"award-number":["CG21APR1005"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001609-00"],"award-info":[{"award-number":["MOH-001609-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001500-00"],"award-info":[{"award-number":["MOH-001500-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF-000352-00"],"award-info":[{"award-number":["NRF-000352-00"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2021\/034\/TRP\/09\/Nanomedicine"],"award-info":[{"award-number":["NUHSRO\/2021\/034\/TRP\/09\/Nanomedicine"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["23-0173-A0001"],"award-info":[{"award-number":["23-0173-A0001"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2020\/133\/Startup\/08"],"award-info":[{"award-number":["NUHSRO\/2020\/133\/Startup\/08"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2023\/008\/NUSMed\/TCE\/LOA"],"award-info":[{"award-number":["NUHSRO\/2023\/008\/NUSMed\/TCE\/LOA"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biomaterials.2025.123387","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:54:57Z","timestamp":1746586497000},"page":"123387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Tumor microenvironment responsive nano-PROTAC for BRD4 degradation enhanced cancer photo-immunotherapy"],"prefix":"10.1016","volume":"322","author":[{"given":"Zheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingwen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0718-9128","authenticated-orcid":false,"given":"Jianhua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-0870","authenticated-orcid":false,"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib1","first-page":"17","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib2","first-page":"1","article-title":"Cancer incidence and mortality in China, 2016","volume":"2","author":"Zheng","year":"2022","journal-title":"J. Natl. Cancer Cent."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biomaterials.2025.123387_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100647","article-title":"Major advances in targeted protein degradation: protacs, LYTACs, and MADTACs","volume":"296","author":"Alabi","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123387_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2025.123387_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","article-title":"Targeted protein degradation: elements of PROTAC design","volume":"50","author":"Paiva","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123387_bib7","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1039\/D2CS00478J","article-title":"PROTAC degraders as chemical probes for studying target biology and target validation","volume":"51","author":"N\u011bmec","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123387_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41589-020-00652-y","article-title":"PROTAC-Mediated degradation reveals a non-catalytic function of AURORA-A kinase","volume":"16","author":"Adhikari","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123387_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202100270","article-title":"Recent developments in PROTAC\u2010mediated protein degradation: from bench to clinic","volume":"23","author":"Hu","year":"2022","journal-title":"Chembiochem"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123387_bib10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","article-title":"Advancing targeted protein degradation for cancer therapy","volume":"21","author":"Dale","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123387_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2020.02.006","article-title":"PROTACs: a novel strategy for cancer therapy","volume":"67","author":"Liu","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biomaterials.2025.123387_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.692574","article-title":"PROTAC: an effective targeted protein degradation strategy for cancer therapy","volume":"12","author":"Qi","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43556-022-00112-0","article-title":"An overview of PROTACs: a promising drug discovery paradigm","volume":"3","author":"Liu","year":"2022","journal-title":"Mol. Biomed."},{"issue":"26","key":"10.1016\/j.biomaterials.2025.123387_bib14","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.1521738113","article-title":"PROTAC-Induced BET protein degradation as a therapy for castration-resistant prostate cancer","volume":"113","author":"Raina","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"6_suppl","key":"10.1016\/j.biomaterials.2025.123387_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.2022.40.6_suppl.017","article-title":"Phase 1\/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC)","volume":"40","author":"Gao","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103395","article-title":"PROTAC technology: a new drug design for chemical biology with many challenges in drug discovery","volume":"28","author":"Guedeney","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123387_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/acsmedchemlett.9b00597","article-title":"PROTAC technology: opportunities and challenges","volume":"11","author":"Gao","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123387_bib18","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1039\/D2CS00387B","article-title":"Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders","volume":"51","author":"Diehl","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1021\/acsmedchemlett.0c00556","article-title":"Solution conformations shed light on PROTAC cell permeability","volume":"12","author":"Atilaw","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123387_bib20","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1039\/D2CS00200K","article-title":"Target and tissue selectivity of PROTAC degraders","volume":"51","author":"Guenette","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123387_bib21","first-page":"273","article-title":"Current strategies for the design of PROTAC linkers: a critical review. Explor. Target","volume":"1","author":"Troup","year":"2020","journal-title":"Antitumor Ther"},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123387_bib22","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123387_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123387_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202114957","article-title":"Smart nano\u2010PROTACs reprogram tumor microenvironment for activatable photo\u2010metabolic cancer immunotherapy","volume":"61","author":"Zhang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"30","key":"10.1016\/j.biomaterials.2025.123387_bib26","doi-asserted-by":"crossref","first-page":"16642","DOI":"10.1021\/jacs.3c04109","article-title":"Self-assembled nano-PROTAC enables near-infrared photodynamic proteolysis for cancer therapy","volume":"145","author":"Wang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"37","key":"10.1016\/j.biomaterials.2025.123387_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202308049","article-title":"Nano proteolysis targeting chimeras (PROTACs) with anti\u2010hook effect for tumor therapy","volume":"135","author":"Zhang","year":"2023","journal-title":"Angew. Chem."},{"issue":"29","key":"10.1016\/j.biomaterials.2025.123387_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202202039","article-title":"Versatile nano\u2010PROTAC\u2010induced epigenetic reader degradation for efficient lung cancer therapy","volume":"9","author":"Zhang","year":"2022","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123387_bib29","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/sj.bjc.6603033","article-title":"Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies","volume":"94","author":"Simmonds","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123387_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc723","article-title":"Natural products in cancer chemotherapy: past, present and future","volume":"2","author":"Mann","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"23","key":"10.1016\/j.biomaterials.2025.123387_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202402516","article-title":"Carrier-free self-assembly nano-sonosensitizers for sonodynamic-amplified cuproptosis-ferroptosis in glioblastoma therapy","volume":"11","author":"Zhu","year":"2024","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123387_bib32","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1039\/D3CS00162H","article-title":"Advancing nanotechnology for neoantigen-based cancer theranostics","volume":"53","author":"Zou","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2025.123387_bib33","first-page":"414","article-title":"pH\/GSH dual responsive nanosystem for nitric oxide generation enhanced type I photodynamic therapy","volume":"34","author":"Zou","year":"2024","journal-title":"Bioact. Mater."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123387_bib34","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1039\/D1CS00647A","article-title":"Organic photosensitizers for antimicrobial phototherapy","volume":"51","author":"Nguyen","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123387_bib35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2020.04.095","article-title":"Role of phototherapy in the era of biologics","volume":"84","author":"Torres","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.biomaterials.2025.123387_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120557","article-title":"Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy","volume":"268","author":"Huang","year":"2021","journal-title":"Biomaterials"},{"issue":"15","key":"10.1016\/j.biomaterials.2025.123387_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202005155","article-title":"Monotherapy and combination therapy using anti\u2010angiogenic nanoagents to fight cancer","volume":"33","author":"Liang","year":"2021","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123387_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202414146","article-title":"Self-assembled peptide-derived proteolysis-targeting chimera (PROTAC) nanoparticles for tumor-targeted and durable PD-L1 degradation in cancer immunotherapy","volume":"64","author":"Moon","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"38","key":"10.1016\/j.biomaterials.2025.123387_bib39","article-title":"Light-triggered PROTAC nanoassemblies for photodynamic IDO proteolysis in cancer immunotherapy","volume":"36","author":"Choi","year":"2024","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123387_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202208553","article-title":"Checkpoint Nano-PROTACs for activatable cancer photo-immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib41","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41467-021-23194-w","article-title":"Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123387_bib42","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/annonc\/mdx157","article-title":"BET inhibitors: a novel epigenetic approach","volume":"28","author":"Doroshow","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123387_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cellimm.2019.02.001","article-title":"Emerging roles of and therapeutic strategies targeting BRD4 in cancer","volume":"337","author":"White","year":"2019","journal-title":"Cell. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123387_bib44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41416-020-0907-6","article-title":"BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene","volume":"123","author":"Yamamoto","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib45","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1038\/s41467-021-24687-4","article-title":"Stromal induction of BRD4 phosphorylation results in chromatin remodeling and BET inhibitor resistance in colorectal cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib46","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41467-020-14604-6","article-title":"A combination strategy targeting enhancer plasticity exerts synergistic lethality against BETi-resistant leukemia cells","volume":"11","author":"Guo","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1387-5","article-title":"Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer","volume":"38","author":"Noblejas-L\u00f3pez","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123387_bib48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1021\/acs.biochem.9b00848","article-title":"PROTACs as potential therapeutic agents for cancer drug resistance","volume":"59","author":"Sun","year":"2019","journal-title":"Biochemistry"},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123387_bib49","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1074\/jbc.RA117.000443","article-title":"Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1","volume":"293","author":"Fahey","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.biomaterials.2025.123387_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201900321","article-title":"Near\u2010infrared\u2010II molecular dyes for cancer imaging and surgery","volume":"31","author":"Zhu","year":"2019","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123387_bib51","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/acsnano.8b08346","article-title":"In situ dendritic cell vaccine for effective cancer immunotherapy","volume":"13","author":"Yang","year":"2019","journal-title":"ACS Nano"},{"issue":"44","key":"10.1016\/j.biomaterials.2025.123387_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202103627","article-title":"Singlet oxygen \u201cAfterglow\u201d therapy with NIR-II fluorescent molecules","volume":"33","author":"Zou","year":"2021","journal-title":"Adv. Mater."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123387_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210037","article-title":"Boosting ferroptosis therapy with iridium single\u2010atom nanocatalyst in ultralow metal content","volume":"35","author":"Cheng","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12967-022-03545-x","article-title":"The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer","volume":"20","author":"Pang","year":"2022","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123387_bib55","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1074\/jbc.RA118.004712","article-title":"Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells","volume":"294","author":"Gayle","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biomaterials.2025.123387_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119705","article-title":"Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer","volume":"280","author":"Alam","year":"2021","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123387_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309562","article-title":"Ultrathin clay nanoparticles-mediated mutual reinforcement of ferroptosis and cancer immunotherapy","volume":"36","author":"Liu","year":"2024","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123387_bib58","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/imr.12574","article-title":"Cell death and immunity in cancer: from danger signals to mimicry of pathogen defense responses","volume":"280","author":"Garg","year":"2017","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123387_bib60","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41467-024-44963-3","article-title":"Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225003060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225003060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:32:32Z","timestamp":1778632352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225003060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":60,"alternative-id":["S0142961225003060"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123387","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor microenvironment responsive nano-PROTAC for BRD4 degradation enhanced cancer photo-immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123387"}}